This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jason D. Morrow, MD; Tanya A. Minton, MS; Joseph A. Awad, MD; L. Jackson Roberts, MD

Arch Dermatol. 1994;130(11):1408-1412.

Abstract
Background and Design
Sorbic acid is a preservative that can induce cutaneous vasodilation characterized by erythema, urticaria, and stinging when applied topically to humans. Previous studies have suggested that prostaglandins may mediate the vasodilation, but the prostaglandin responsible has not been established. Recently, we have shown that cutaneous erythema similar to that associated with the application of sorbic acid is induced by topical administration of methylnicotinate and is mediated by the release of prostaglandin D₂ (PGD₂) from the skin. Therefore, we examined whether the cutaneous vasodilation induced by sorbic acid is also mediated by this prostaglandin in humans.

Results
Topical application of 1% sorbic acid to the forearms of four human volunteers resulted in 250- to 620- fold increases in levels of PGD₂ and 15- to 58-fold increases in levels of the metabolite of PGD₂, 9,11β-PGF₂, in blood drawn from the antecubital vein draining the treated sites. There were no increases in the release of the other vasodilatory prostaglandins, PGE₂ or prostacyclin (PGI₂). The release of PGD₂ in response to topically applied sorbic acid occurred in a dose-dependent manner and was not accompanied by a release of histamine, suggesting that the release of PGD₂ was not from the mast cell.

Conclusions
The cutaneous vasodilation that occurs following the administration of sorbic acid is primarily due to a release of PGD₂ from a cellular source in the skin.

(Arch Dermatol. 1994;130:1408-1412)

Footnotes
From the Departments of Pharmacology and Medicine, Vanderbilt University School of Medicine, Nashville, Tenn.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Annual Review of Cosmetic Ingredient Safety Assessments: 2005/2006
International Journal of Toxicology 2008;27:77-142.
FULL TEXT